The antibiotic drug tigecycline: A focus on its promising anticancer properties

• Главные авторы: Zhijie Xu (Автор), Yuanliang Yan (Автор), Zhi Li (Автор), Long Qian (Автор), Zhicheng Gong (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2016-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Tigecycline (TIG), the first member of glycylcycline bacteriostatic agents, has been approved to treat complicated infections in the clinic because of its expanded-spectrum antibiotic potential. Recently, an increasing number of studies have emphasized the anti-tumor effects of TIG. The inhibitory e...